Brink’s targets early January 2027 NCR Atleos close while projecting $275M-$295M Q4 adjusted EBITDA

• "In the third quarter, we delivered 4% organic growth with organic growth in ATM managed services and digital retail solutions, or AMS/DRS, accelerating sequentially to over 16%." (CEO, President & Director Richard Eubanks)

• "AMS/DRS now represents 30% of our trailing 12-month revenue mix after reaching a record 32% in the third quarter." (CEO Eubanks)

• "Adjusted EBITDA margins were 19.9% in the quarter, up 90 basis points year-on-year, while operating profit margins expanded by 100 basis points." (CEO Eubanks)

• "Trailing 12-month free cash flow was $413 million with conversion of 40%" and "drove an expected leverage reduction to 2.6x in the quarter." (CEO Eubanks)

• "We're pulling forward our expected closing date again and now expect to close the transaction in early January of 2027" and the company still expects "our full $200 million run rate synergy projection by the end of 2029." (CEO Eubanks)

• "Revenue increased by 3% with 4% organic growth, a 1% foreign currency tailwind and a 2% revenue decline from the previously disclosed deconsolidation of our Malaysian business." (Executive VP & CFO Kurt McMaken)

Outlook

• "Our framework for 2026 is unchanged." (CFO McMaken)

• "In the fourth quarter, we expect revenue between $1.365 billion and $1.415 billion, reflecting between 3% and 4.5% organic growth." (CFO McMaken)

• "Adjusted EBITDA is expected to be between $275 million and $295 million, reflecting adjusted EBITDA margin expansion of approximately 40 basis points to 20.5% at the midpoint." (CFO McMaken)

• "EPS is expected to be between $2.45 and $2.80." (CFO McMaken)

• Compared with the prior quarter’s Q3 guide, management’s Q4 outlook raised the implied margin midpoint (Q3 guide midpoint 19.6% vs. Q4 guide midpoint 20.5%) and also introduced a stated FX headwind for Q4: "FX is expected to be a little more than 1% headwind in the quarter" vs. Q2 commentary that Q3 FX was "flat to less than a percentage point of benefit year-on-year." (CFO McMaken)

Financial Results

• "Adjusted EBITDA was up 8% to $274 million, and operating profit was up 11% to $208 million." (CFO McMaken)

• "EPS of $2.46 per share reflects growth of 18%." (CFO McMaken)

• "Operating profit was up $20 million to $208 million with a margin of 15.1%" and "interest expense was $66 million in the quarter." (CFO McMaken)

• "Tax expense was $39 million in the quarter, representing an effective tax rate of 27.2%" and "income from continuing operations was $102 million on 41.5 million diluted shares." (CFO McMaken)

• "Depreciation and amortization was $61 million in the quarter" and "stock-based compensation was $5 million in Q3." (CFO McMaken)

Q&A

• Keen Fai Tong, Goldman Sachs: "Can you quantify the revenue and EBITDA associated with those businesses" being divested in the U.K. for CMA clearance? Executive VP & CFO McMaken: "The business runs about $120 million, $130 million in revenues" with "EBITDA margins kind of in the mid- to high 20s" and "about a $30 million EBITDA kind of impact"; CEO Eubanks added, "We had no -- none of our $200 million worth of cost synergies contemplated" from NoteMachine.

• Keen Fai Tong, Goldman Sachs: asked whether backlog supports sustaining mid- to high teens AMS/DRS growth into 2027 vs. moderating. CEO Eubanks: "our DRS backlog alone is up 80% versus prior year" and "What we've heard from customers directly... is they're delaying some decisions based on waiting for what the combined offer looks like" while noting Q3 saw "more acceleration of conversions" from CVM into AMS/DRS.

• Timothy Mulrooney, William Blair: questioned how broad-based the U.S. DRS backlog increase is. CEO Eubanks: "We announced a big retailer last quarter, about 5,500 locations" but "we have a pretty broad-based backlog right now" including "some 10s and 20 locations, some hundreds of locations... thousands of locations."

• Timothy Mulrooney, William Blair: asked if new wins include lower cash-use customers and about Latin America headwinds. CEO Eubanks: "We certainly are" expanding beyond "the highest cash users"; on the region, he cited "digital payment adoption" in Brazil via "the Pix network," plus "some economic headwinds in Argentina" and "some retail weakness in Mexico."

• Tobey Sommer, Truist: asked what the NCR Atleos combination could unlock for customers. CEO Eubanks: "integrating the entire value chain" could "squeeze out inefficiencies in costs as well as cash that's tied up in their system" and management expects the sales process to shift "less about a brochure" and more like "a whiteboard session."

• Christopher Senyek, Wolfe Research: asked whether identified synergies are revenue or cost and about memory costs exposure. CEO Eubanks: "those are largely cost synergies" and the company is "not looking to take out sales infrastructure"; on memory, he said, "on the Brink's side, no real impact" and the company would expect to "pass that through in pricing" if needed.

Sentiment Analysis

• Analysts’ tone was slightly negative to neutral, with detailed diligence on remedies, growth durability, macro/digital-payment pressure, and cost inflation risk; for example, Goldman asked to "quantify" divestiture economics and Wolfe probed whether synergies are "revenue side or the cost side" and asked about "memory costs." (Keen Fai Tong, Goldman Sachs; Christopher Senyek, Wolfe Research)

• Management’s tone was positive and execution-focused, emphasizing acceleration, backlog visibility, and integration confidence, including "we remain confident" on mid- to high teens AMS/DRS growth and "increasing confidence in the significant synergy potential above our original estimates." (CEO Eubanks)

• Versus last quarter, management’s language strengthened on the deal timeline (from "early in the first quarter" to "early January of 2027") and became more specific on remedies and synergy upside, while analyst questions expanded from regulatory timing and AMS adoption pace to divestiture economics and component-cost risk. (CEO Eubanks; CFO McMaken)

Quarter-over-quarter comparison

• The transaction timeline moved earlier quarter-over-quarter: in Q2, Brink’s said it "moved our estimated closing timeline forward to early in the first quarter"; in Q3, it said, "now expect to close the transaction in early January of 2027." (CEO Eubanks)

• Prepared remarks shifted from approaching North America’s margin milestone (Q2: "coming in at 19.8% on a trailing 12-month basis") to reporting it achieved (Q3: "we reached 20% adjusted EBITDA margins in our North America segment"). (CEO Eubanks)

• The Q&A focus broadened quarter-over-quarter: Q2 concentrated on AMS/DRS drivers, ATM outsourcing pace, and regulatory gating items; Q3 concentrated on divestiture remedy economics, backlog durability into 2027, synergy composition, and input-cost exposure. (CEO Eubanks; CFO McMaken)

Risks and Concerns

• Regulatory and remedy risk remained active, including required divestitures: the company discussed agreeing "to divest your NoteMachine and TestLink businesses in the U.K." and indicated proceeds were uncertain: "We really can't talk about sales proceeds because we don't really know yet." (CFO McMaken)

• Growth mix headwinds were acknowledged: "Organic growth was down 1.5%, reflecting faster conversion to AMS/DRS" in CVM, alongside "continued moderation" in global services. (CEO Eubanks)

• FX and structure impacts were flagged for near-term results: Q3 included "the dollar strengthened considerably" and Q4 outlook includes "a little more than 1% headwind" plus ongoing revenue impact from the Malaysia deconsolidation. (CFO McMaken)

Final Takeaway

Management emphasized accelerating AMS/DRS momentum (including an 80% year-over-year increase in U.S. DRS backlog), record-margin progression culminating in North America reaching a trailing 12-month 20% adjusted EBITDA margin, and an accelerated NCR Atleos closing target of early January 2027 alongside reiterated $200 million run-rate synergy plans by end of 2029, while also addressing regulatory remedies (including planned U.K. divestitures) and guiding Q4 2026 to $1.365 billion-$1.415 billion revenue, $275 million-$295 million adjusted EBITDA, and $2.45-$2.80 EPS.

Read the full Earnings Call Transcript

Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.